SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-17-063140
Filing Date
2017-10-20
Accepted
2017-10-20 16:31:19
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 a17-24147_1s3.htm S-3 329390
2 EX-5.1 a17-24147_1ex5d1.htm EX-5.1 17436
3 EX-23.1 a17-24147_1ex23d1.htm EX-23.1 4066
4 EX-23.2 a17-24147_1ex23d2.htm EX-23.2 3613
5 GRAPHIC g241471kgi001.jpg GRAPHIC 1868
6 GRAPHIC g241471kmi001.gif GRAPHIC 7075
7 GRAPHIC g241471kmi002.gif GRAPHIC 1382
8 GRAPHIC g241471kmi003.gif GRAPHIC 6464
9 GRAPHIC g241471bci001.jpg GRAPHIC 5612
  Complete submission text file 0001104659-17-063140.txt   386883
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221041 | Film No.: 171147292
SIC: 2834 Pharmaceutical Preparations